Resources from the same session
Systemic therapy for adjuvant ER+ and when is ovarian suppression warranted?
Presenter: S. C. Lee, SG
Session: Module 3 - Early ER+ Breast Cancer – Part I
Resources:
Slides
Webcast
Best systemic therapy high risk ER+ HER2 negative breast cancer (choice of chemo, role of CDKi)?
Presenter: S. Kuemmel, DE
Session: Module 3 - Early ER+ Breast Cancer – Part I
Resources:
Slides
Webcast
Participant clinical case discussion: Early breast cancer in pregnancy
Presenter: J. Munchar Elias, MY
Session: Module 3 - Early ER+ Breast Cancer – Part I
Resources:
Slides
Webcast
Participant clinical case discussion: Discordance in hormone receptor status on core needle biopsy and on lumpectomy specimens in a case of invasive breast carcinoma, right, stage IA (pT1c pN0(sn) M0)
Presenter: A. F. Chan, PH
Session: Module 3 - Early ER+ Breast Cancer – Part I
Resources:
Slides
Webcast